Peter Attia· MD
and I know lots of lipid ologists who are still putting LP little-a patients on niacin even though there are no data to suggest that that will save their lives
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and I know lots of lipid ologists who are still putting LP little-a patients on niacin even though there are no data to suggest that that will save their lives
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
where you get some who say nice and should never be used and then you get others who say look it's probably not a great drug but if you have a patient who can't take anything else it's still a good drug